Concepedia

Marisa Peluso

MP

4

Publications

249

Citations

4

H-Index

2014

Active since

Affiliations

Infinity Pharmaceuticals (United States)(Current)

Marisa Peluso is an author at Infinity Pharmaceuticals (United States) specializing in medicine, cell signaling, and cell biology.

ORCID

Top concepts

Publications per year

2014–2025

4

Publications

4

The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL

Kumudha Balakrishnan, Marisa Peluso, Min Fu et al. · Leukemia · 2015 · 165 citations · Full text

, , +11

Mining the CRBN target space redefines rules for molecular glue–induced neosubstrate recognition

Georg Petzold, Pablo Gaínza, Stefano Annunziato et al. · Science · 2025 · 42 citations

Duvelisib (IPI-145) Inhibits Malignant B-Cell Proliferation and Disrupts Signaling from the Tumor Microenvironment through Mechanisms That Are Dependent on PI3K-δ and PI3K-γ

Marisa Peluso, David A. Winkler, Nidhi Patel et al. · Blood · 2014 · 25 citations

Impact of the Smoothened Inhibitor, IPI-926, on Smoothened Ciliary Localization and Hedgehog Pathway Activity

Marisa Peluso, Veronica T. Campbell, Joseph A. Harari et al. · PLoS ONE · 2014 · 17 citations · Full text

, , +15

Rows per page

1–4 of 4